Adamis Pharmaceuticals Corporation total revenue, net income and dynamics of changes in Euro today
Adamis Pharmaceuticals Corporation net revenue for today is 3 637 332 €. The dynamics of Adamis Pharmaceuticals Corporation net income fell by -12 884 611 € for the last reporting period. These are the main financial indicators of Adamis Pharmaceuticals Corporation. Graph of the financial report of Adamis Pharmaceuticals Corporation. The financial report chart shows the values from 31/12/2018 to 31/12/2020. Adamis Pharmaceuticals Corporation net income is shown in blue on the graph.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Dates of Adamis Pharmaceuticals Corporation finance reports: 31/12/2018, 30/09/2020, 31/12/2020. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Adamis Pharmaceuticals Corporation is 31/12/2020. Gross profit Adamis Pharmaceuticals Corporation is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Adamis Pharmaceuticals Corporation is 760 731 €
Cost of revenue Adamis Pharmaceuticals Corporation is the total cost of producing and distributing of products and services of a company. Cost of revenue Adamis Pharmaceuticals Corporation is 2 876 601 € Total revenue Adamis Pharmaceuticals Corporation refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Adamis Pharmaceuticals Corporation is 3 637 332 € Operating income Adamis Pharmaceuticals Corporation is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Adamis Pharmaceuticals Corporation is -13 777 372 €
Net income Adamis Pharmaceuticals Corporation is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Adamis Pharmaceuticals Corporation is -20 369 809 € Current assets Adamis Pharmaceuticals Corporation is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Adamis Pharmaceuticals Corporation is 12 524 121 € Total assets Adamis Pharmaceuticals Corporation refers to the total amount of assets owned by a person or entity. Total assets Adamis Pharmaceuticals Corporation is 30 867 462 €
31/12/2020
30/09/2020
30/06/2020
31/03/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
706 627.81 €
607 646.36 €
-703 620.10 €
906 741.07 €
1 495 910.15 €
1 950 029.37 €
1 189 247.85 €
1 034 686.86 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
2 672 017.14 €
3 387 014.16 €
4 350 720.65 €
3 424 821.43 €
3 987 245.27 €
3 404 870.02 €
3 367 625.64 €
2 823 794.27 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
3 378 644.95 €
3 994 660.52 €
3 647 100.56 €
4 331 562.50 €
5 483 155.42 €
5 354 899.38 €
4 556 873.50 €
3 858 481.13 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-12 797 525.30 €
-6 352 793.31 €
-8 821 024.39 €
-6 608 922.68 €
-6 509 967.24 €
-7 195 801.14 €
-8 302 027.55 €
-12 320 094.92 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-18 921 108.18 €
-6 952 850.72 €
-10 461 708.85 €
-9 542 727 €
-6 501 928.71 €
-7 185 432.05 €
-8 255 239.87 €
-11 899 655.96 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 355 035.28 €
1 578 547.96 €
2 866 360.20 €
1 891 879.62 €
3 082 714 €
2 643 355.62 €
2 040 297.92 €
7 245 937.44 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
16 176 170.25 €
10 347 453.82 €
12 468 124.95 €
10 940 485.19 €
11 993 122.65 €
12 550 700.52 €
12 858 901.05 €
16 178 576.05 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
11 633 405.51 €
15 920 013.01 €
11 142 931.79 €
14 243 537.88 €
17 006 382.76 €
11 120 441.75 €
16 249 230.38 €
23 950 476.93 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
28 672 168.10 €
40 789 432.78 €
36 879 935.70 €
42 059 213.60 €
49 083 082.77 €
43 740 146.43 €
48 917 140.21 €
54 207 622.70 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
6 367 802.15 €
11 496 917.75 €
7 329 980.64 €
9 758 832.79 €
11 259 803.48 €
3 801 616.96 €
8 536 478.72 €
17 901 042.82 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
10 064 127.78 €
10 646 710.17 €
10 586 470.44 €
10 732 000.86 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
11 649 709.22 €
12 335 841.29 €
11 967 171.60 €
10 836 527.72 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
23.73 %
28.20 %
24.46 %
19.99 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
3 248 794.96 €
25 446 706.61 €
21 476 523.01 €
30 853 617.70 €
37 433 373.55 €
31 404 305.14 €
36 949 968.61 €
43 371 094.97 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-3 954 940.68 €
-4 102 050.19 €
-7 685 271.67 €
-11 402 631.78 €
Last revenue report of Adamis Pharmaceuticals Corporation was 31/12/2020. According to last financial report total revenue in Adamis Pharmaceuticals Corporation was 3 378 644.95 Euro and changed by -12.436% since last year. Net income in Adamis Pharmaceuticals Corporation was -18 921 108.18 € in last quartal, net income changes to 0%.
Current cash Adamis Pharmaceuticals Corporation - the sum of all of the cash a company has on the date of report. Current cash Adamis Pharmaceuticals Corporation is 6 855 355 €
